|
시장보고서
상품코드
2008105
원숭이두창 치료 시장 : 치료법별, 투여 경로별, 유통 채널별, 지역별Monkeypox Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
원숭이두창 치료 시장은 2026년에 1억 3,480만 달러로 추정되며, 2033년까지 4억 2,240만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 18.5%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 1억 3,480만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 18.50% | 예측 금액(2033년) | 4억 2,240만 달러 |
원숭이두창(엠폭스)로 알려진 희귀 질환은 원숭이두창 바이러스에 감염되어 발생합니다. 천연두 바이러스와 원숭이두창 바이러스는 같은 바이러스과에 속합니다. 하지만 원숭이두창의 경우 천연두만큼 전염력이 강하지 않습니다. 또한, 이 병의 증상은 비교적 경미하며 일반적으로 치명적이지 않습니다. 원숭이두창의 주요 증상은 발진이며, 생식기나 그 주변에 나타날 수 있습니다.
1958년, 연구용으로 사육되던 원숭이 무리에서 발생한 천연두와 유사한 증상을 보이는 두 번의 집단 발병이 계기가 되어 원숭이두창이 발견되었습니다. 감염자와의 피부 접촉을 통해 전파되기도 하지만, 감염된 사람과 설치류와의 접촉이 감염 경로의 대부분을 차지합니다. 원숭이두창 바이러스는 두 가지 유형이 있는데, 하나는 중앙아프리카, 다른 하나는 서아프리카에서 유래했습니다.
과거 원숭이두창에 감염된 사람들의 대부분은 중앙아프리카나 서아프리카의 특정 지역에 거주했거나, 해당 지역을 방문했거나, 해당 지역에서 수입된 감염된 동물과 접촉한 적이 있습니다. 2022년 전염병에서는 미국을 포함한 여러 국가의 거주자에게서 이 질병이 확인되었습니다.
시장 역학
미국 보건복지부는 2022년 8월 4일, 원숭이두창을 공중보건 비상사태로 선포했습니다. 이로 인해 원숭이두창에 대한 백신과 보다 효과적인 치료법에 대한 수요가 가속화되고 있습니다. 원숭이두창 감염의 확산과 백신 및 새로운 치료법에 대한 수요 증가가 세계 원숭이두창 치료 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2022년 6월 현재 WHO에 따르면, 2022년 1월 1일부터 6월 22일까지 WHO의 5개 지역 50개 국가 및 지역에서 3,413건의 확진 사례와 1건의 사망 사례가 보고되었습니다. 또한, 아프리카 지역, 아메리카 지역, 동부 지중해 지역, 서태평양 지역 등 8개국에서 1,310명의 신규 확진자가 보고되었습니다. 2022년 2분기에 나이지리아에서 1명의 사망자가 보고되었습니다.
본 보고서의 주요 특징
- 세계의 원숭이두창 치료 시장에 대해 조사 분석했으며, 2021년을 기준 연도로 하여 예측 기간(2022-2030년)의 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 세계 원숭이두창 치료 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 작성되었습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 종류 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 원숭이두창 치료 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 원숭이두창 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 원숭이두창 치료 시장 : 치료법별(2026-2033년)
제5장 원숭이두창 치료 시장 : 투여 경로별(2026-2033년)
제6장 원숭이두창 치료 시장 : 유통 채널별(2026-2033년)
제7장 원숭이두창 치료 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSMMonkeypox Treatment Market is estimated to be valued at USD 134.8 Mn in 2026 and is expected to reach USD 422.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 134.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 18.50% | 2033 Value Projection: | USD 422.4 Mn |
A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and the monkeypox virus both belong to the same virus family. Monkey pox, however, is not as contagious as smallpox. Additionally, the illness has lesser symptoms and is typically not fatal. The major symptom of Monkeypox is rash that may be located on or near the genitals.
Two outbreaks of a condition resembling the pox that were occurring in groups of monkeys being used for research led to the discovery of monkeypox in 1958. Although, skin-to-skin contact with an infected person can sometimes spread the disease, rodent contact with infected humans accounts for the majority of its transmission. The monkeypox virus has two distinct types, one of which originated in Central Africa and the other in West Africa.
The majority of those who contracted monkeypox in the past either resided and visited specific regions of central or western Africa, or exposed to diseased animals imported from such regions. The disease has been identified in residents of several nations, including the U.S., during the 2022 outbreak.
Market Dynamics
The U.S. Department of Health and Human Services, on August 4 2022 declared monkeypox outbreak as a public health emergency. Due to which there is acceleration in the demand for vaccines and better treatment for monkeypox. Increase in the prevalence of monkeypox disease and increasing demand for vaccines and new treatment for monkeypox is expected to drive growth of the global monkeypox treatment market. For instance, in June 2022, according to the WHO, since 1 January to 22 June 2022, 3413 laboratory confirmed cases and one death have been reported to the WHO from 50 countries/territories in the five WHO Regions. Moreover, 1310 new cases have been reported in eight new countries from regions like African Region, Region of the Americas, Eastern Mediterranean Region and Western Pacific Region.One death was reported in Nigeria in the second quarter of 2022.
Key features of the study
- This report provides an in-depth analysis of the global monkeypox treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global monkeypox treatment market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
- Key companies covered as a part of this study include SIGA Technologies, Inc., Bavarian Nordic, Sanofi SA, and Emcure Pharma, Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global monkeypox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox treatment market
Market Segmentation
- By Treatment Type
- Prophylactic (Vaccines)
- Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)
- By Route of Administration
- Oral
- Injectable
- By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- SIGA Technologies Inc.
- Bavarian Nordic
- Sanofi SA.
- Emcure Pharma
- Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Monkeypox Treatment Market, By Treatment Type, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Prophylactic (Vaccines)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
5. Monkeypox Treatment Market, By Route of Administration, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
6. Monkeypox Treatment Market, By Distribution Channel, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
7. Monkeypox Treatment Market, By Region, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- SIGA Technologies Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bavarian Nordic
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sanofi SA.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Emcure Pharma
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
